OBJECTIVES: Venovenous extracorporeal membrane oxygenation has been used to provide cardiopulmonary support in critically ill infants and children. Recently, dual-lumen venovenous extracorporeal membrane oxygenation has gained popularity in the pediatric population. Herein, we report our institutional experience using a bicaval dual-lumen catheter for pediatric venovenous extracorporeal membrane oxygenation support, which has been our unified approach for venovenous extracorporeal membrane oxygenation since 2009. DESIGN: This study is a retrospective review. SETTING: The setting is a tertiary children's hospital in a major metropolitan area. PATIENTS: Between 2009 and 2011, 11 patients were cannulated using a dual-lumen bicaval venous catheter. Patient demographics, cannulation details, circuit complications, complications of catheter use, and patient outcomes were collected from a retrospective chart review. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Eleven of the patients were cannulated for venovenous extracorporeal membrane oxygenation using the dual-lumen bicaval cannula. The median age at the time of venovenous cannulation was 1.9 years (range, 0.14-17.1), and the median weight was 10.2 kg (range, 3-84). Three patients (27%) required conversion to venoarterial extracorporeal membrane oxygenation. The median duration of extracorporeal membrane oxygenation support was 10 days (2-38 days). Fifty-five percent of patients suffered from a bleeding complication (disseminated intravascular coagulation, pulmonary hemorrhage, or intraventricular hemorrhage), and 45% had a circuit complication. Adequate flow rates were achieved in all patients. The overall hospital mortality in the series was 55%. There were no cannula-related complications. CONCLUSIONS: This review presents the first single-institution experience with the dual-lumen Avalon cannula in pediatric patients. Preliminary results indicate that the catheter can be safely placed and has an acceptable complication profile; however, continued study within larger trials is necessary to fully ascertain the clinical profile of this catheter.
OBJECTIVES: Venovenous extracorporeal membrane oxygenation has been used to provide cardiopulmonary support in critically ill infants and children. Recently, dual-lumen venovenous extracorporeal membrane oxygenation has gained popularity in the pediatric population. Herein, we report our institutional experience using a bicaval dual-lumen catheter for pediatric venovenous extracorporeal membrane oxygenation support, which has been our unified approach for venovenous extracorporeal membrane oxygenation since 2009. DESIGN: This study is a retrospective review. SETTING: The setting is a tertiary children's hospital in a major metropolitan area. PATIENTS: Between 2009 and 2011, 11 patients were cannulated using a dual-lumen bicaval venous catheter. Patient demographics, cannulation details, circuit complications, complications of catheter use, and patient outcomes were collected from a retrospective chart review. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Eleven of the patients were cannulated for venovenous extracorporeal membrane oxygenation using the dual-lumen bicaval cannula. The median age at the time of venovenous cannulation was 1.9 years (range, 0.14-17.1), and the median weight was 10.2 kg (range, 3-84). Three patients (27%) required conversion to venoarterial extracorporeal membrane oxygenation. The median duration of extracorporeal membrane oxygenation support was 10 days (2-38 days). Fifty-five percent of patients suffered from a bleeding complication (disseminated intravascular coagulation, pulmonary hemorrhage, or intraventricular hemorrhage), and 45% had a circuit complication. Adequate flow rates were achieved in all patients. The overall hospital mortality in the series was 55%. There were no cannula-related complications. CONCLUSIONS: This review presents the first single-institution experience with the dual-lumen Avalon cannula in pediatric patients. Preliminary results indicate that the catheter can be safely placed and has an acceptable complication profile; however, continued study within larger trials is necessary to fully ascertain the clinical profile of this catheter.
Authors: Richard H Trimlett; Jeremy J Cordingley; Mark J Griffiths; Susanna Price; David N Hunter; Simon J Finney Journal: Intensive Care Med Date: 2011-03-24 Impact factor: 17.440
Authors: Jeffrey Javidfar; Daniel Brodie; Dongfang Wang; Ali N Ibrahimiye; Jonathan Yang; Joseph B Zwischenberger; Joshua Sonett; Matthew Bacchetta Journal: Ann Thorac Surg Date: 2011-06 Impact factor: 4.330
Authors: Michael D Rollins; Ania Hubbard; Luke Zabrocki; Douglas C Barnhart; Susan L Bratton Journal: J Pediatr Surg Date: 2012-01 Impact factor: 2.545
Authors: Keith A Kuenzler; L Grier Arthur; Andrew E Burchard; Stephen T Lawless; Philip J Wolfson; Stephen G Murphy Journal: J Pediatr Surg Date: 2002-05 Impact factor: 2.545
Authors: Timothy H Thomas; Ryan Price; Claudio Ramaciotti; Marita Thompson; Steve Megison; Matthew S Lemler Journal: Pediatr Crit Care Med Date: 2009-01 Impact factor: 3.624
Authors: Yigit S Guner; Robinder G Khemani; Faisal G Qureshi; Choo Phei Wee; Mary T Austin; Fred Dorey; Peter T Rycus; Henri R Ford; Philippe Friedlich; James E Stein Journal: J Pediatr Surg Date: 2009-09 Impact factor: 2.545
Authors: Brian W Gray; Jonathan W Haft; Jennifer C Hirsch; Gail M Annich; Ronald B Hirschl; Robert H Bartlett Journal: ASAIO J Date: 2015 Jan-Feb Impact factor: 2.872
Authors: Jennifer L Carpenter; Yangyang R Yu; Darrell L Cass; Oluyinka O Olutoye; James A Thomas; Cole Burgman; Caraciolo J Fernandes; Timothy C Lee Journal: Pediatr Surg Int Date: 2018-01-18 Impact factor: 1.827
Authors: Vanessa Marie Bazan; Evan Michael Taylor; Tyler Michael Gunn; Joseph Bertram Zwischenberger Journal: Indian J Thorac Cardiovasc Surg Date: 2020-03-31